DE19632423A1 - Thienopyrimidine - Google Patents

Thienopyrimidine

Info

Publication number
DE19632423A1
DE19632423A1 DE19632423A DE19632423A DE19632423A1 DE 19632423 A1 DE19632423 A1 DE 19632423A1 DE 19632423 A DE19632423 A DE 19632423A DE 19632423 A DE19632423 A DE 19632423A DE 19632423 A1 DE19632423 A1 DE 19632423A1
Authority
DE
Germany
Prior art keywords
pyrimidine
chloro
pyridin
thieno
methylthieno
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19632423A
Other languages
German (de)
English (en)
Inventor
Rochus Dr Jonas
Pierre Prof Dr Schelling
Franz-Werner Dr Kluxen
Maria Christadler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE19632423A priority Critical patent/DE19632423A1/de
Priority to DK97940047T priority patent/DK0920431T3/da
Priority to DE59709404T priority patent/DE59709404D1/de
Priority to CZ1999448A priority patent/CZ287772B6/cs
Priority to US09/230,806 priority patent/US6110920A/en
Priority to KR10-1999-7001153A priority patent/KR100502271B1/ko
Priority to SK164-99A priority patent/SK282823B6/sk
Priority to JP50934398A priority patent/JP4405593B2/ja
Priority to ES97940047T priority patent/ES2191192T3/es
Priority to HK00100583.3A priority patent/HK1021731B/xx
Priority to CA002263561A priority patent/CA2263561C/en
Priority to PCT/EP1997/004139 priority patent/WO1998006722A1/de
Priority to UA99031300A priority patent/UA55421C2/uk
Priority to AU42035/97A priority patent/AU725227B2/en
Priority to PT97940047T priority patent/PT920431E/pt
Priority to NZ334600A priority patent/NZ334600A/xx
Priority to TR1999/00308T priority patent/TR199900308T2/xx
Priority to EP97940047A priority patent/EP0920431B1/de
Priority to RU99104796/04A priority patent/RU2199541C2/ru
Priority to CN97197179A priority patent/CN1081638C/zh
Priority to HU0001607A priority patent/HUP0001607A3/hu
Priority to AT97940047T priority patent/ATE233265T1/de
Priority to PL97331538A priority patent/PL190174B1/pl
Priority to BR9711062A priority patent/BR9711062A/pt
Priority to SI9730518T priority patent/SI0920431T1/xx
Priority to IL12850497A priority patent/IL128504A/xx
Priority to ZA9707156A priority patent/ZA977156B/xx
Priority to TW086111481A priority patent/TW359672B/zh
Priority to ARP970103649A priority patent/AR009052A1/es
Publication of DE19632423A1 publication Critical patent/DE19632423A1/de
Priority to NO990643A priority patent/NO990643D0/no
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19632423A 1996-08-12 1996-08-12 Thienopyrimidine Withdrawn DE19632423A1 (de)

Priority Applications (30)

Application Number Priority Date Filing Date Title
DE19632423A DE19632423A1 (de) 1996-08-12 1996-08-12 Thienopyrimidine
TR1999/00308T TR199900308T2 (xx) 1996-08-12 1997-07-30 Tiyenopirimidinler
NZ334600A NZ334600A (en) 1996-08-12 1997-07-30 Thienopyrimidines inhibiting phosphodiesterase V for treating cardiovascular disease and impotency
CZ1999448A CZ287772B6 (en) 1996-08-12 1997-07-30 Thienopyrimidine derivative, process of its preparation and pharmaceutical preparation in which it is comprised
US09/230,806 US6110920A (en) 1996-08-12 1997-07-30 Thienopyrimidines
KR10-1999-7001153A KR100502271B1 (ko) 1996-08-12 1997-07-30 티에노피리미딘
SK164-99A SK282823B6 (sk) 1996-08-12 1997-07-30 Derivát tienopyrimidínu, spôsob jeho prípravy a farmaceutický prostriedok, ktorý ho obsahuje
JP50934398A JP4405593B2 (ja) 1996-08-12 1997-07-30 チエノピリミジン類
ES97940047T ES2191192T3 (es) 1996-08-12 1997-07-30 Tienopirimidinas.
HK00100583.3A HK1021731B (en) 1996-08-12 1997-07-30 Thienopyrimidines
CA002263561A CA2263561C (en) 1996-08-12 1997-07-30 Thienopyrimidines
PCT/EP1997/004139 WO1998006722A1 (de) 1996-08-12 1997-07-30 Thienopyrimidine
UA99031300A UA55421C2 (uk) 1996-08-12 1997-07-30 Тієнопіримідини, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб її одержання
AU42035/97A AU725227B2 (en) 1996-08-12 1997-07-30 Thienopyrimidines
PT97940047T PT920431E (pt) 1996-08-12 1997-07-30 Tienopirimidinas
DK97940047T DK0920431T3 (da) 1996-08-12 1997-07-30 Thienopyrimidiner.
CN97197179A CN1081638C (zh) 1996-08-12 1997-07-30 噻吩并嘧啶化合物
DE59709404T DE59709404D1 (en) 1996-08-12 1997-07-30 Thienopyrimidine
RU99104796/04A RU2199541C2 (ru) 1996-08-12 1997-07-30 Тиенопиримидины, способ их получения (варианты), фармацевтическая композиция и способ ее получения
EP97940047A EP0920431B1 (de) 1996-08-12 1997-07-30 Thienopyrimidine
HU0001607A HUP0001607A3 (en) 1996-08-12 1997-07-30 Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds
AT97940047T ATE233265T1 (de) 1996-08-12 1997-07-30 Thienopyrimidine
PL97331538A PL190174B1 (pl) 1996-08-12 1997-07-30 Nowe związki, tienopirymidyny, sposób ich wytwarzania oraz preparat farmaceutyczny
BR9711062A BR9711062A (pt) 1996-08-12 1997-07-30 Tienopirimidinas
SI9730518T SI0920431T1 (en) 1996-08-12 1997-07-30 Thienopyrimidines
IL12850497A IL128504A (en) 1996-08-12 1997-07-30 2-HETEROARYL-N-PHENYL (ALKYL) THIENO [2,3-d] PYRIMIDIN-4-AMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ZA9707156A ZA977156B (en) 1996-08-12 1997-08-11 Thienopyrimidines.
TW086111481A TW359672B (en) 1996-08-12 1997-08-11 Thienopyrimidines ad phosphodiesterase V antagonists, process for the production thereof and pharmaceutical compositions containing the same
ARP970103649A AR009052A1 (es) 1996-08-12 1997-08-12 Tienopirimidinas, un procedimiento para su preparacion, empleo de las mismas para preparar un medicamento, preparaciones farmaceuticas que lascontienen y un procedimiento para obtener estas preparaciones farmaceuticas
NO990643A NO990643D0 (no) 1996-08-12 1999-02-11 Tienopyrimidiner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19632423A DE19632423A1 (de) 1996-08-12 1996-08-12 Thienopyrimidine

Publications (1)

Publication Number Publication Date
DE19632423A1 true DE19632423A1 (de) 1998-02-19

Family

ID=7802392

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19632423A Withdrawn DE19632423A1 (de) 1996-08-12 1996-08-12 Thienopyrimidine
DE59709404T Expired - Lifetime DE59709404D1 (en) 1996-08-12 1997-07-30 Thienopyrimidine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE59709404T Expired - Lifetime DE59709404D1 (en) 1996-08-12 1997-07-30 Thienopyrimidine

Country Status (28)

Country Link
US (1) US6110920A (enExample)
EP (1) EP0920431B1 (enExample)
JP (1) JP4405593B2 (enExample)
KR (1) KR100502271B1 (enExample)
CN (1) CN1081638C (enExample)
AR (1) AR009052A1 (enExample)
AT (1) ATE233265T1 (enExample)
AU (1) AU725227B2 (enExample)
BR (1) BR9711062A (enExample)
CA (1) CA2263561C (enExample)
CZ (1) CZ287772B6 (enExample)
DE (2) DE19632423A1 (enExample)
DK (1) DK0920431T3 (enExample)
ES (1) ES2191192T3 (enExample)
HU (1) HUP0001607A3 (enExample)
IL (1) IL128504A (enExample)
NO (1) NO990643D0 (enExample)
NZ (1) NZ334600A (enExample)
PL (1) PL190174B1 (enExample)
PT (1) PT920431E (enExample)
RU (1) RU2199541C2 (enExample)
SI (1) SI0920431T1 (enExample)
SK (1) SK282823B6 (enExample)
TR (1) TR199900308T2 (enExample)
TW (1) TW359672B (enExample)
UA (1) UA55421C2 (enExample)
WO (1) WO1998006722A1 (enExample)
ZA (1) ZA977156B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261863C2 (ru) * 2000-06-29 2005-10-10 Мерк Патент Гмбх 2-аминоалкилтиено[2,3-d]пиримидины, способ их получения, лекарственный препарат и способ его получения

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine
US6331571B1 (en) 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
CA2365578A1 (en) 1999-03-30 2000-10-12 Seiichi Uchida Thienopyrimidine compounds and salts thereof and process for the preparation of the same
US6399826B1 (en) 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
DE19950647A1 (de) * 1999-10-21 2001-04-26 Merck Patent Gmbh Imidazolderivate als Phosphodiesterase VII-Hemmer
CA2423981A1 (en) * 2000-09-29 2003-03-28 Kimiko Ichikawa Thienopyrimidine compounds and salts thereof and process for the preparation of the same
CZ20032350A3 (en) * 2001-02-02 2004-03-17 Merck Patent Gmbh PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO 4,3-d PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
CN101100472A (zh) * 2001-04-30 2008-01-09 美国拜尔公司 4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
DE60207280T2 (de) * 2001-09-04 2006-05-18 Akzo Nobel N.V. GLYCINSUBSTITUIERTE THIENO[2,3-d]PYRIMIDINE MIT KOMBINIERTER LH- UND FSH-AGONISTISCHER WIRKUNG
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
US7153412B2 (en) 2001-12-28 2006-12-26 Kabushiki Kaisha Toyota Chuo Kenkyusho Electrodes, electrochemical elements, gas sensors, and gas measurement methods
US7276529B2 (en) 2002-03-20 2007-10-02 Celgene Corporation Methods of the treatment or prevention of exercise-induced asthma using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7208516B2 (en) 2002-03-20 2007-04-24 Celgene Corporation Methods of the treatment of psoriatic arthritis using (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
US7893101B2 (en) 2002-03-20 2011-02-22 Celgene Corporation Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
US6962940B2 (en) 2002-03-20 2005-11-08 Celgene Corporation (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
TW200410975A (en) * 2002-09-26 2004-07-01 Nihon Nohyaku Co Ltd New pesticide and method for using it, new substituted thienopyrimidine derivative, its intermediate, and method for producing it
GB0320300D0 (en) * 2003-08-29 2003-10-01 Cancer Rec Tech Ltd Pyrimidothiophene compounds
DE10351436A1 (de) * 2003-11-04 2005-06-09 Merck Patent Gmbh Verwendung von Thienopyrimidinen
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
GB0420722D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
US9603848B2 (en) 2007-06-08 2017-03-28 Senomyx, Inc. Modulation of chemosensory receptors and ligands associated therewith
BRPI0816970A2 (pt) * 2007-09-14 2015-03-24 Ortho Mcneil Janssen Pharm 1,3-dissubstituídas-4-fenil-1h-piridin-2-onas
EA017648B1 (ru) * 2007-09-14 2013-02-28 Орто-Макнейл-Янссен Фармасьютикалз, Инк. 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2н,1'н-[1,4']бипириди-нил-2'-оны
TW200922566A (en) 2007-09-14 2009-06-01 Ortho Mcneil Janssen Pharm 1,3 disubstituted 4-(aryl-X-phenyl)-1H-pyridin-2-ones
CA2704436C (en) * 2007-11-14 2016-01-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
US20100227853A1 (en) * 2008-04-18 2010-09-09 Trustees Of Boston College Inhibitors of cyclic amp phosphodiesterases
EP3085699B1 (en) 2008-07-31 2022-03-02 Firmenich Incorporated Processes for making sweet taste enhancers
JP5547194B2 (ja) 2008-09-02 2014-07-09 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としての3−アザビシクロ[3.1.0]ヘキシル誘導体
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
JP5690277B2 (ja) 2008-11-28 2015-03-25 ジャンセン ファーマシューティカルズ, インコーポレイテッド. 代謝型グルタミン酸受容体の調節因子としてのインドールおよびベンゾオキサジン誘導体
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
CN102439015B (zh) 2009-05-12 2015-05-13 杨森制药有限公司 1,2,4-三唑并[4,3-a]吡啶衍生物和其作为mGluR2受体的正向变构调节剂的用途
HRP20131122T1 (hr) 2009-05-12 2013-12-20 Janssen Pharmaceuticals, Inc. Derivati 1,2,4-triazolo[4,3-a] piridina i njihova uporaba u lijeäśenju ili prevenciji neuroloških i psihijatrijskih poremeä†aja
ES2536433T3 (es) 2010-11-08 2015-05-25 Janssen Pharmaceuticals, Inc. Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2
JP5852664B2 (ja) 2010-11-08 2016-02-03 ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド 1,2,4−トリアゾロ[4,3−a]ピリジン誘導体およびmGluR2受容体のポジティブアロステリックモジュレーターとしてのそれらの使用
EP2661435B1 (en) 2010-11-08 2015-08-19 Janssen Pharmaceuticals, Inc. 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
US9056877B2 (en) 2011-07-19 2015-06-16 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
AU2013299859B2 (en) 2012-08-06 2017-06-15 Firmenich Incorporated Sweet flavor modifier
JO3155B1 (ar) 2013-02-19 2017-09-20 Senomyx Inc معدِّل نكهة حلوة
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
PL3096790T3 (pl) 2014-01-21 2020-01-31 Janssen Pharmaceutica, N.V. Kombinacje zawierające pozytywne modulatory allosteryczne lub agonistów ortosterycznych metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie
ME03518B (me) 2014-01-21 2020-04-20 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore ili ortosterične agoniste metabotropnog glutamatergičnog receptora podtipa 2 i njihova primjena
WO2015200177A1 (en) 2014-06-23 2015-12-30 Celgene Corporation Apremilast for the treatment of a liver disease or a liver function abnormality
WO2017112777A1 (en) 2015-12-22 2017-06-29 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
KR102736865B1 (ko) 2017-06-21 2024-12-03 샤이 테라퓨틱스 엘엘씨 암, 염증성 질환, 신경발달질환 및 섬유증 질환의 치료를 위하여 Ras 수퍼패밀리와 상호작용하는 화합물
WO2020033420A1 (en) 2018-08-07 2020-02-13 Firmenich Incorporated 5-substituted 4-amino-1h-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof
JP7407461B2 (ja) 2018-12-19 2024-01-04 シャイ・セラピューティクス・エルエルシー がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物
CN116178374B (zh) * 2023-01-13 2024-10-08 河北医科大学 小电导钙激活钾离子通道激动剂及其合成和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
ZA782648B (en) * 1977-05-23 1979-06-27 Ici Australia Ltd The prevention,control or eradication of infestations of ixodid ticks
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 4−アミノキナゾリン誘導体およびそれを含有する医薬品
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2261863C2 (ru) * 2000-06-29 2005-10-10 Мерк Патент Гмбх 2-аминоалкилтиено[2,3-d]пиримидины, способ их получения, лекарственный препарат и способ его получения

Also Published As

Publication number Publication date
PL190174B1 (pl) 2005-11-30
KR20000029932A (ko) 2000-05-25
AR009052A1 (es) 2000-03-08
NO990643L (no) 1999-02-11
RU2199541C2 (ru) 2003-02-27
WO1998006722A1 (de) 1998-02-19
NO990643D0 (no) 1999-02-11
HUP0001607A2 (hu) 2000-10-28
SI0920431T1 (en) 2003-08-31
UA55421C2 (uk) 2003-04-15
JP4405593B2 (ja) 2010-01-27
NZ334600A (en) 2000-07-28
PL331538A1 (en) 1999-07-19
BR9711062A (pt) 1999-08-17
PT920431E (pt) 2003-07-31
TR199900308T2 (xx) 1999-04-21
JP2000516223A (ja) 2000-12-05
US6110920A (en) 2000-08-29
EP0920431B1 (de) 2003-02-26
KR100502271B1 (ko) 2005-07-22
HUP0001607A3 (en) 2002-09-30
AU4203597A (en) 1998-03-06
AU725227B2 (en) 2000-10-12
DK0920431T3 (da) 2003-06-02
CN1227560A (zh) 1999-09-01
ES2191192T3 (es) 2003-09-01
HK1021731A1 (en) 2000-06-30
ATE233265T1 (de) 2003-03-15
CZ44899A3 (cs) 1999-05-12
CA2263561C (en) 2007-02-20
IL128504A (en) 2003-01-12
SK16499A3 (en) 1999-06-11
EP0920431A1 (de) 1999-06-09
SK282823B6 (sk) 2002-12-03
DE59709404D1 (en) 2003-04-03
CZ287772B6 (en) 2001-01-17
CA2263561A1 (en) 1998-02-19
IL128504A0 (en) 2000-01-31
CN1081638C (zh) 2002-03-27
ZA977156B (en) 1998-02-19
TW359672B (en) 1999-06-01

Similar Documents

Publication Publication Date Title
EP0920431B1 (de) Thienopyrimidine
WO1998017668A1 (de) Thienopyrimidine mit pde v inhibierender wirkung
EP1036078B1 (de) Thienopyrimidine
DE19533975A1 (de) Arylalkyl-diazinone
EP1337256A2 (de) Verwendung von thienopyrimidinen
EP1210349B1 (de) Pyrazolo[4, 3-d]pyrimidine
EP1084125B1 (de) Kondensierte thienopyrimidine mit pde v inhibierender wirkung
DE19928146A1 (de) Thienopyrimidine
DE10064994A1 (de) Sulfamidothienopyrimidine
EP1355649A2 (de) Pharmazeutische formulierung enthaltend pyrazolo 4,3-d]pyrimidine und nitrate oder thienopyrimidine und nitrate
DE10058662A1 (de) Verwendung von Pyrazolo[4,3-d]pyrimidinen
EP1294729B1 (de) 2-aminoalkyl-thieno[2,3-d]pyrimidine
EP1351962A2 (de) Thienopyrimidine
DE19944604A1 (de) Aminderivate
DE19943815A1 (de) Verwendung von Thienopyrimidinen
MXPA99001387A (en) Thienopyrimidines
DE10104096A1 (de) Pharmazeutische Formulierung enthaltend Thienopyrimidine und Nitrate
DE10104801A1 (de) Pharmazeutische Formulierungen enthaltend Thienopirimidine und Endothelin-Rezeptor-Antagonisten (2)

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee